Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer hid death data in COV-19 vaccine clinical trials
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(151)
•••
Comment by menoalittleon Oct 31, 2023 11:06am
149 Views
Post# 35709210

RE:RE:RE:RE:Pfizer hid death data in COV-19 vaccine clinical trials

RE:RE:RE:RE:Pfizer hid death data in COV-19 vaccine clinical trials>> 5 to 40 percent will get the virus 

Seriously ???  How many people do you actually know haven't yet had some form of the virus, and have been tested to prove that they haven't yet had it? Very, very few (if any, even) that I personally know of or have talked to.

Seems that the vast majority of people (over 75%) either know they've already had Covid (vaccinated or not), including a good many that didn't think they'd had it - yet, when tested for it, tested positive for having had it- ...or they've not yet been tested for it!  Think I'm kidding or don't know what I'm talking about?  Then don't believe me, and continue to think or say whatever you want.  Of course, you could always check the Internet to try and learn more about it....

How many Americans still haven’t caught COVID-19? CDC publishes final 2022 estimates | The Transmission | University of Nebraska Medical Center (unmc.edu)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities